Part D Direct Negotiations Top AARP’s 2007 Advocacy Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
In addition to supporting lifting the ban on HHS directly negotiating prices with drug makers, AARP will push for legislation on drug importation and a pathway for generic biologics.